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Bronchioloalveolar carcinoma remains one of the most enigmatic lung cancers, demonstrating varied growth patterns, mixed
histological features, and confusing clinical manifestations. This paper reports a case of an unusual form of presentation: a
sclerosing type associated with desmoplastic reaction and cicatrization. A 75-year-old woman was admitted with persistent
dry cough and progressive dyspnea. Physical examination showed bilateral inspiratory crackles. A chest radiograph and high-
resolution computed tomography demonstrated conﬂuent airspace nodules, forming areas of consolidation in both lungs, with
signs of architectural distortion. The lung biopsy revealed a nonmucinous sclerosing bronchioloalveolar carcinoma.
1.Introduction
There has been a substantial increase in the percentage of
pulmonary adenocarcinoma accompanied with a decrease
in squamous cell carcinoma in recent decades [1]. Bronchi-
oloalveolar carcinoma (BAC) represents 1.5%–6.5% of all
primary pulmonary neoplasms. Most patients are between
40 and 70 years of age [2].
BAC is derived from the epithelial cells located distally
to the terminal bronchioles, and is deﬁned as a primary
lung cancer in peripheral locations. It is found growing in a
lepidic (scale-like) manner near the alveolar septae without
parenchymal, vascular, or pleural invasion [3]. BAC has a
distinct clinical, pathological, and radiological presentation
compared to the other subtypes of adenocarcinoma. In the
majority of cases, BAC appears as a peripheral pulmonary
nodule; however, the tumor may present as a segmental,
lobar consolidation, with a multifocal or diﬀuse pattern
[3, 4]. In this report, we describe a case of BAC in a 75-year-
old woman with an unusual presentation: a nonmucinous
sclerosing type associated with desmoplastic reaction and
cicatrization.
2. Case Presentation
A 75-year-old woman presented with a persistent dry cough
that had been present for 2 months together with progressive
dyspnea, anorexia, fatigue, malaise, and a weight loss of 5kg
during the same period. She did not have a fever, chills
or sweats. There was no history of smoking, alcohol abuse
or primary malignancy. Physical examination showed the
patient to be ill-looking, acyanotic, eupneic, and afebrile.
Her blood pressure was 100/60mmHg, her pulse rate was
80 beats per minute, her respiratory rate was 24 breaths
per minute, and her body temperature was 36.4◦C. She
had inspiratory crackles in the bilateral lower lung ﬁelds.
Laboratory tests showed normal RBC and WBC count,
serum creatinine was 0.6mg/dL, urea was 23mg/dL, glucose
was 102mg/dL, and liver function tests were normal.2 Case Reports in Medicine
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Figure 1: Chest radiographs in anteroposterior (a) and lateral incidence (b) showing hyperinﬂated lungs, with bilateral nonhomogeneous
opacities, predominantly in the middle third of right lung.
(a) (b)
(c) (d)
Figure 2: HRCT scans at four levels (a)–(d) demonstrate conﬂuent airspace nodules and areas of consolidation in both lungs, with signs
of architectural distortion that are characterized by bronchial dilatations within the lesions (white arrowheads in (a)) and ﬁssure distortion
with loss of the regularity (white small arrows in (d)).
A chest radiograph revealed bilateral nonhomogeneous
opacities, predominantly in the middle third of the right
lung (Figure 1). The high-resolution computed tomography
(HRCT) demonstrated conﬂuent airspace nodules, form-
ing areas of consolidation in both lungs, with signs of
architectural distortion (Figure 2). Bronchoscopy showed
no abnormalities. Microscopical examination and cultures
of sputum and bronchoalveolar lavage were negative for
mycobacteriaandfungi.Acytologicalevaluationofasputum
specimen revealed no malignant cells. The lung biopsy
revealed nonmucinous sclerosing BAC (Figure 3).
The oncologists chose palliative treatment with clini-
cal supports and analgesia due to the advanced state of
the disease. Since her performance status was ECOG 4,
chemotherapy could not be used. She died one month after
the admission with respiratory failure.Case Reports in Medicine 3
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Figure 3: (a)–(c): Photomicrographs demonstrate active young ﬁbroblast proliferation (ﬁbrosis) and tumor cells that are entrapped within
the central desmoplasia. (d): Photomicrograph shows neoplastic cells spreading along alveolar septa (lepidic growth) with preservation of
the alveolar architecture (hematoxylin-eosin stain).
3. Discussion
This paper reports a case of BAC, which is an uncommon
type of bronchial carcinoma that occurs most frequently
among nonsmokers, women, and Asians [2]. According to
the revised World Health Organization (WHO) lung tumor
classiﬁcation,BACisdeﬁnedasasubtypeofadenocarcinoma
with intra-alveolar spread and lepidic growth along an intact
interstitial framework, yet with no evidence of stromal,
vascular or pleural invasion [5]. The distinguishing feature
of this carcinoma is the preservation of the underlying lung
architecture. BAC tends to spread through the airways, but
lymphatic and hematogenous dissemination may occur in
50% to 60% of cases [2, 6]. Though a tumor resection might
prove helpful in other cases, complete resection of the tumor
could only conﬁrm the diagnosis of pure BAC since some
other invasive adenocarcinomas also contain the BAC com-
ponent. WHO classiﬁcation is very useful in diﬀerentiating
BAC from other tumors with BAC components. Despite
appropriate classiﬁcations, patients seek medical care once
the cancer has substantially advanced or is metastatic. In the
majority of these cases complete resection is not feasible [7].
Similarly, our patient presented with a multifocal advanced
disease.
BAC is classiﬁed into three diﬀerent subtypes: mucinous,
nonmucinous, or mixed (including both types) [8]. In the
sclerosing form of nonmucinous BAC, the intratumoral
alveolar septa, while intact, are thickened by ﬁbrosis and
inﬂammation. In addition, there is dense central sclerosis,
whichentrapsanddistortsthelinearlyspreadingtumorcells,
giving the appearance of invasive glands [9]. Our case is an
interesting example of nonmucinous sclerosing BAC, which
demonstrated a diﬀuse and multicentric growth pattern with
desmoplastic reaction. While a biopsy is focal, the use of
imaging can conﬁrm whether a diﬀuse alveolar inﬁltrate is
present in both lungs. The HRCT pattern was homogeneous
and the same pattern was seen in all the pulmonary lobes.
Based on these results, one can infer that the histological
ﬁndings would also be similar.
More than half of all patients with BAC are asymp-
tomatic and remain without symptoms even as the disease
disseminates. The most frequently reported symptoms and
signs are cough, sputum, shortness of breath, weight loss,
hemoptysis, and fever. Bronchorrhea is unusual and is a late
manifestation seen only with diﬀuse BAC [2]. The clinical
presentation of our patient was similar to that in previously
documented cases.
There are three diﬀerent radiological patterns seen
in BAC: a solitary nodule or mass of varying density,
focal consolidation, or multifocal (diﬀuse) disease [5]. The
most common radiological ﬁnding is a solitary peripheral,
lobulated or ill-marginated pulmonary nodule or mass.
Other CT features include pseudocavitation (bubble-like
low attenuating region within a nodule), heterogeneous
attenuation, and irregular margins forming a star pattern
and pleural tags, which are thought to be caused by a
desmoplasticreactionintheperipheralseptaofthelung[10].4 Case Reports in Medicine
Focal isolated ground-glass opacity has been described as
an early ﬁnding of BAC, especially in cases where there are
associated pseudocavities and air bronchograms [5].
The consolidative form of BAC (30% of cases) corre-
spondstoamucinoushistologicalsubtype,andmaybefocal,
ill-deﬁned, ground-glass, lobar or multifocal. Because lobar
consolidation can be diﬃcult to diﬀerentiate from pneu-
monia in plain radiography images, the diagnosis is often
delayed. Evaluation by CT provides additional information
needed for diagnosis. Nonresolving central or peripheral
consolidation, especially with associated nodules, raises the
possibilityofBAC.Thenodulesarepredominantlycentrilob-
ular, reﬂecting an endobronchial distribution. Peribronchial
nodules may represent lymphatic spread. As the tumor ﬁlls
the alveolar spaces and inﬁltrates the alveolar septa and
bronchial walls, the bronchus becomes narrowed, stretched
and rigid. Bulging of the interlobar ﬁssure is a characteristic
ﬁnding in consolidative BAC, and is probably a result of
mucin production in the tumor, resulting in swelling of the
lobe [6, 11].
If contrasted CT is performed, the “CT angiogram” sign
can be seen. This sign represents the enhancement of unaf-
fected pulmonary vessels coursing through low-attenuation
consolidated lung parenchyma, ﬁlled with mucus and ﬂuid.
This featureis not speciﬁc,and may be seen in BAC, obstruc-
tive pneumonitis, pneumonia, pulmonary lymphoma, and
lipoid pneumonia [12]. High-resolution CT ﬁndings of
diﬀuse BAC include ground-glass opacity (most common),
consolidation, nodules, centrilobular nodules, peripheral
distribution, air bronchogram, and lower lung predomi-
nance. The diﬀuse nodular form is often indistinguishable
from miliary tuberculosis or metastatic thyroid carcinoma
[6]. Extensive ground-glass airspace opaciﬁcation associated
with septal thickening (the “crazy paving” pattern) has also
been described [13].
The chest radiograph of our patient showed nonho-
mogeneous opacities and the HRCT revealed a pattern
of consolidation and airspace nodules. The HRCT also
demonstrated lung architectural distortion that was char-
acterized by bronchial dilatations within the lesions and
ﬁssure distortion with loss of the normal regularity. Given
the diﬀuse pattern of airspace occupation that occurred
with a chronic course (two months), the main diagnostic
hypotheses were infectious diseases (especially tuberculosis
and fungal diseases) and neoplastic diseases (especially
bronchioloalveolar carcinoma and lymphoma). The absence
of fever and the laboratory test results reduced the prob-
ability of there being an infectious disease. Furthermore,
bronchoalveolar lavage and sputum culture were negative
for mycobacteria and fungi, making neoplastic etiology
a more probable cause. The pulmonary biopsy revealed
nonmucinous bronchioloalveolar carcinoma, with evidence
of associated ﬁbrosis (sclerosing component).
The prognosis of this disease depends on the stage, based
on the nature and extent of the spread of the neoplasm. A
localized area of segmental or lobar consolidation represents
a better prognosis than does the diﬀuse disease [2, 4].
Although the grade of ﬁbroblastic proliferation and ﬁbrotic
scarring (central ﬁbrosis) are important prognostic factors
for bronchioloalveolar carcinomas [14–16] in patients with
advanced BAC, death typically occurs from respiratory
failure secondary to diﬀuse pulmonary involvement rather
than from spread of the disease to other organ sites. This
is attributed to the fact that BAC is characterized by diﬀuse
alveolar ﬁlling, which frequently results in hypoxemic respi-
ratory failure [14, 17]. In our patient, the rapid evolution to
death was most likely the result of extension of the lesions,
with diﬀuse airspace occupation.
Surgical resection is the only potentially curative treat-
ment; however, multifocal diseases remains problematic,
as treatment options are limited. One multicenter review
of lung transplantation for multifocal BAC reported a 5-
year survival rate of 39%. Although it is rarely curative,
lung transplantation remains a valuable option for patients
with impending respiratory failure secondary to advanced
multifocal BAC [18].
In conclusion, BAC may present with a variety of
CT appearances and is associated with variable prognoses
depending upon whether the diseased tissue is focal or
diﬀuse. Features such as the CT angiogram sign or air
bronchograms in solitary nodules and in the periphery of
larger consolidations may lead the radiologist to determine
the diagnosis. Persisting pure ground-glass opacities, unre-
solving consolidation, and a combination of diﬀuse nodules
and consolidation found in these tests should alert the
radiologist to consider a diagnosis of BAC [5]. Ultimately,
sclerosing BAC must be considered when CT scans reveal
architectural distortion that anatomopathologically corre-
sponds to desmoplastic reaction and ﬁbrosis.
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